Physician

Apostolos A. Paul Rossos, M.D.

According to 2025 Medicare claims, Apostolos Rossos, M.D. (NPI: 1710074562) practices otolaryngology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. Rossos uses personal NPI as billing NPI and primary practice location at 08619-3829.

Rossos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 313 traditional Medicare patients, billed 1,149 HCPCS/CPT codes, and received $83,220 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 420 prescription claims across 150 beneficiaries totaling $19,432 in drug costs, led by Ciprofloxacin-Dexamethasone (Ciprofloxacin Hcl/Dexameth). DME data shows 38 claims. Open Payments data shows 5 records totaling $169. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $171,833 to $83,220. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $17,428 and ending at $19,432. In contrast, DME billing represents a smaller volume and rose steadily, from $572 to $3,810.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	717	2,413	$171,833
2016	690	2,352	$169,922
2017	559	1,948	$135,768
2018	561	1,969	$123,698
2019	498	1,873	$126,266
2020	412	1,436	$92,205
2021	406	1,448	$100,945
2022	373	1,344	$97,751
2023	313	1,196	$90,136
2024	313	1,149	$83,220

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	204	532	$17,428
2016	189	519	$17,537
2017	192	547	$19,969
2018	178	549	$15,559
2019	186	560	$23,720
2020	173	551	$26,750
2021	156	498	$24,984
2022	166	437	$20,333
2023	156	401	$23,093
2024	150	420	$19,432

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	13	$326
2018	N/R	N/R	N/R
2019	N/R	13	$319
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$332
2024	N/R	38	$806

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	147	249	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	102	152	$68
69210	Removal of impacted ear wax	108	150	$37
92557	Comprehensive hearing and speech recognition test	136	149	$29
92570	Comprehensive hearing test	96	103	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	12	551	$1,202
Mometasone Furoate	Mometasone Furoate	26	1,334	$1,016
Fluticasone Propionate	Fluticasone Propionate	64	3,660	$983
Ipratropium Bromide	Ipratropium Bromide	30	1,605	$960
Azelastine Hcl	Azelastine Hcl	27	1,410	$861

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	26	$675
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	12	$132

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$169	Optinose US, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Apostolos A. Paul Rossos, M.D.?

Tedicare shows public-source Medicare data for Apostolos A. Paul Rossos, M.D. (NPI 1710074562), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Apostolos A. Paul Rossos, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Apostolos A. Paul Rossos, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Apostolos A. Paul Rossos, M.D. have Open Payments data?

Apostolos A. Paul Rossos, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.